Researchers at Baylor College of Medicine have developed an experimental drug called CS18 that may help cancer treatments work against… Read More »This new drug could break cancer’s resistance to treatment
Mesothelioma is a rare and aggressive cancer that is often related to asbestos exposure. When asbestos fibers are inhaled, they… Read More »A new drug against mesothelioma activates the cancer’s own defenses
A low dose of digoxin can help people with heart failure avoid hospitalization and reduce the risk of death, according… Read More »This 10-cent heart drug reduces hospitalizations by 25%
Researchers at King’s College London have identified a promising new strategy for tackling Alzheimer’s disease by targeting several of the… Read More »New Alzheimer’s drug repairs DNA damage and reduces brain inflammation
Miles WangAn OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery is leaving the maker of… Read More »OpenAI researcher Miles Wang in talks to launch $2 billion AI drug discovery startup
Readers Respond The previous question was from a letter writer who was concerned about the working conditions at their condominium.… Read More »My Aunt Pretends My Cousin Doesn’t Have a Drug Problem. Do I Have to Play Along?
An experimental drug developed at Michigan Medicine has demonstrated the ability to reverse severe fatty liver disease in animal studies… Read More »Experimental drug reverses severe fatty liver disease by repairing the intestine
A rare and aggressive form of liver cancer has long resisted immunotherapy, a treatment that helps the body’s own immune… Read More »FDA-Approved Drug May Finally Help Immunotherapy Beat Rare Liver Cancer
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.… Read More »Philippines’ ex-president Rodrigo Duterte arrested over drug war killings
Budget and staffing cuts at the Food and Drug Administration orchestrated by President Donald Trump could prevent new drugs “from… Read More »Trump’s FDA Cuts Are Putting Drug Development at Risk
